Try our Advanced Search for more refined results

Teva, Mylan Clarify Copaxone Patent Claims

By Elaine Meyer ( December 4, 2009, 4:14 PM EST) -- Teva Pharmaceuticals USA Inc. has clarified that certain infringement allegations don't target Mylan Inc. in a suit filed against the generics maker, its U. S. manufacturer and Natco Pharma Ltd. over a bid to make a copycat version of Teva's multiple sclerosis drug Copaxone. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Law360 Reveals Titans Of The Plaintiffs Bar

This past year, a handful of attorneys secured billions of dollars in settlements and judgments for both classes and individual plaintiffs against massive companies and organizations like Facebook, Dell, the National Association of Realtors, Johnson & Johnson, UFC and Credit Suisse, earning them recognition as Law360's Titans of the Plaintiffs Bar for 2025.